Exploring alternative indicators for trachoma endpoint decision-making (Malawi)

Analyze the relationships between the prevalence of the clinical sign follicular trachoma (TF) and the prevalence of infection and antibody to determine whether it may be appropriate to consider one or more alternative indicators for deciding whether trachoma programs can stop MDA.


Implementation partner(s): Malawi MOH | BICO
WHO Region: AFRO


Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units

Sarah E. Burr, John Hart, Lyson Samikwa, David Chaima, Gretchen Cooley, Diana Martin, Michael Masika, Anthony W. Solomon, Robin L. Bailey, Khumbo Kalua
2019, Issue no. 13, pages (10): e0007749


Email primary contact

Please log in or register